Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders
SALT LAKE CITY, July 22 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, and the University of Utah today announced that they have entered into a collaboration that allows Axial access to the University's rich ...
Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo
CHELMSFORD, Mass., July 16 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical diagnostics, will feature a variety of automated systems and diagnostic tests
designed to help doctors make faster, more-informed treatment decisions in Booth 3244 at the 2009 AACC/ASCLS Cli...
Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. The collaboration will use DxS' industry le...
Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards
HUNTINGTON BEACH, California, and AMSTERDAM, May 28 /PRNewswire/ --
Agendia, a world leader in molecular cancer diagnostics, today announced its
strong support of Genentech's Citizen's Petition. Filed on December 5, 2008,
Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnosti...
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Collaboration with Noted Neurologists to Plan Next Clinical Studies
OMAHA, Neb. and HOUSTON, May 11 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM), announced the clinical introduction of the NuroPro(R) AD an...
New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
AGAWAM, Mass., March 16 /PRNewswire/ -- Contamination by mycoplasmal organisms is an ever-present concern in biopharmaceutical manufacturing. Their properties make them ready sources of contamination, while rendering them difficult and time-consuming to detect. A new free white paper, examines how...
Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection
- Gene Signal International, a Biotech Company Registered in Switzerland, Will Move its Headquarter to the EPFL, in Lausanne,
- Gene Signal is Addressing Various Issues Related to Neovascularisation,
- Gene Signal is Working on a Portfolio of Ophthalmologic Indications, With One Now...
Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Lumiphore, Inc., a
biotechnology leader in the development of new proprietary fluorescent
metal-lanthanide technology for use in high-value applications, announced
that it has signed an exclusive agreement with Biophor Diagnostics, Inc.,
Redwood City, C...
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer
In Addition, the Company has Identified Unique microRNA Biomarkers in the
Serum of Colon ...
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and
Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that 3M has
discontinued the companies' collaboration to develop rapid molecular tests
for healthcare-associated infections (HCAIs).
The companies, which are explor...
Making a good impression: Nanoimprint lithography tests at NIST
In what should be good news for integrated circuit manufacturers, recent studies by the National Institute of Standards and Technology (NIST) have helped resolve two important questions about an emerging microcircuit manufacturing technology called nanoimprint lithographyyes, it can accurately sta...
Genetic Testing for All: QTrait Offers Industry's Least Expensive, Most Secure DNA Tests With TRUSTe Certification
SEATTLE, April 24 /PRNewswire/ -- iGenix, Inc, today launched QTrait, a
personal online genetics testing service with prices beginning as low as
$99 per DNA test. iGenix co-founder and chief scientist Tera Eerkes, Ph.D.
developed QTrait to create affordable DNA testing for the general public,
Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment Tests
Improve Cancer Identification, Help Physicians Develop More Specific Prognosis
GRAND RAPIDS, Mich., March 3 /PRNewswire/ -- The Center for Molecular
Medicine (CMM) today announced an agreement with San Diego-based AviaraDx
to support three new tests
Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
Company Continues to Lead Tropism Testing Field
SOUTH SAN FRANCISCO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc (Nasdaq: MGRM ) today announced that data related to the
company's advanced HIV tropism assay have been presented as multiple
posters during the ...
EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
MANCHESTER, England, September 20 /PRNewswire-FirstCall/ -- EpiStem
(LSE: EHP) announced today that it has completed the first year of
mucositis efficacy-testing services for potential biodefense drugs, and are
about to embark upon an extensive drug screening programme over the coming
BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests
BERLIN, NIMES, France and RICHMOND, Calif., June 22 /PRNewswire/ -- BRAHMS Aktiengesellschaft, a global diagnostics company, Cezanne, and Lumiphore Inc., a biotechnology leader in new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that they have ...
SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
Rapidly growing thyroid test market expands to EU, LATAM and Africa
SAINT JOHN, New Brunswick, March 11 /PRNewswire/ -- Screening Devices Canada, Inc. announces the immediate availability of ThyroChek, the rapid test for elevated TSH, the first clinical indicator of hypothyroidism to countrie...
Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests
SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Pathwork Diagnostics, a
molecular diagnostics company focused on oncology, and City of Hope
Hospital presented today the results from a meta-analysis examining the use
of immunohistochemistry (IHC) to determine the origin of metastatic cancer
at the se...
Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
OSLO, October 28 /PRNewswire-FirstCall/ -- DiaGenic ASA (OSL:DIAG)
today announced that it has signed a service provider agreement with
DNAVision, a leading panEuropean provider of gene expression-based
diagnostic testing and services With this laboratory service and following
CE marking sched...
World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests
Glaucoma Leading Cause of Preventable Blindness in the UK(1) Though Awareness of Symptoms and Risk Factors Remains Low
WALTON OAKS, England, October 9 /PRNewswire/ -- Today on World Sight
Day leading experts aim to raise awareness of the eye disease glaucoma. It
is estimated that t...
Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
Interleukin Genetics Plans to Continue Efforts to Out-License Intellectual Property
WALTHAM, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics,
Inc. (Amex: ILI ), and Access Business Group International LLC, a division
of Alticor Inc., have reached an...
Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests
Roche will market the RAMP(R) cardiovascular product line in the United States and Canada
INDIANAPOLIS, July 28 /PRNewswire/ -- Roche Diagnostics and Response
Biomedical have entered into a partnership that will allow Roche to market
the first line of cardiovascular t...
Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
Rosetta Genomics has Signed a Binding Term Sheet to Acquire Parkway Clinical Laboratories Inc., a Company Owning a Clinical Laboratory Improvement Act (CLIA) Certified Lab
The Acquisition is Intended to Significantly Streamline the Development and Commercialization of Rose...
LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
BURLINGTON, N.C. and ROCKVILLE, M.D., June 5 /PRNewswire-FirstCall/ --
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH ), one
of the world's leading clinical trials and genetic testing laboratories,
and Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical comp...
Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests Tests
identify genetic mutations that can affect patient response to certain cancer drugs
PLEASANTON, Calif., June 2 /PRNewswire/ -- Roche and DxS Ltd. have
signed an exclusive distribution agreement for the DxS TheraScreen K-RAS
Mutation Test and TheraScreen EGFR 29...
Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
Vermillion Obtains Exclusive Rights to Oncology Biomarkers
FREMONT, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Vermillion, Inc.
(Nasdaq: VRML ), a high-value molecular diagnostics company, today announced
the renewal of a long-standing collaboration with Johns Hopkins University
on the d...
Kiwa Fertilizers Pass Independent Tests
BEIJING and CLAREMONT, Calif., Jan. 7 /Xinhua-PRNewswire-FirstCall/ --
Kiwa Bio-Tech Products Group Corporation (KWBT.OB) announced that: Xinjiang
Corps Agro-technology Extended Terminal promulgated the test results on
Kiwa's fertilizer products "Pen Duo Shou" and "Jin Peng Jia Bao", both of
ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
ADVENTRX Presents Results at 2007 AACR-NCI-EORTC International Conference
SAN DIEGO, Oct. 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX ), a biopharmaceutical research and development company
focused on commercializing proprietary product candidates for the treatment
Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
LOD, Israel, October 25 /PRNewswire/ -- Glycominds Ltd., a
bio-diagnostics company specializing in glycan biomarkers for diagnosis and
disease management of autoimmune diseases and cancer, announced today
entering into a research agreement with Fox Chase Cancer Center (FCCC), an
Researchers underscore limitations of genetic ancestry tests
AUSTIN, TexasAlthough many people rely on commercially available genetic tests
for insights into their ancestry, the tests
have significant limitations according to Deborah Bolnick, assistant professor of anthropology at The University of Texas at Austin.
In The Science and Business of Genetic...
BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
ROCKVILLE, Md., Sept. 18 /PRNewswire/ -- BioReliance Corporation, a
leading contract services organization for the biopharmaceutical and
pharmaceutical industries, announced today the launch of iNet, a
proprietary information technology system that enables customers to submit
test article deta...
Quintessence division to develop drug tests with NIH grant
Madison, Wis. — QBI Life Sciences said it has received $175,000 from the National Institutes of Health and formed partnerships with UW-Madison and the University of Helsinki, Finland, to develop new drug tests.
QBI, a division of Quintessence Biosciences Inc. in Madison, will be workin...
UW tests adult stem cell role in regenerative heart care
Madison, Wis . - Can a heart patient's own stem cells be used to repair heart damage?
The University of Wisconsin School of Medicine and Public Health intends to find out as part of a clinical trial now underway at UW Hospital and Clinics .
The school is among the first medical centers in...
Protein Truncation Tests Using the DCode System
Helen Chun, Milhan Telatar and Richard A. Gatti
Department of Pathology, UCLA School of Medicine,
Los Angeles, California
Protein Truncation Testing (PTT) is a method used to screen large coding
regions of DNA to detect ...
Southwestern lab selects Third Wave reagents for Hepatitis tests
MADISON, Wis. Third Wave Technologies Inc. has announced that the southwestern laboratory network TriCore Reference Laboratories has adopted Third Wave's Invader Hepatitis C Virus genotyping reagents.
The reagents are part of tests
that can identify all six types of the Hepatitis C virus, a...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
...to commercialization of VGV-1 in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests
on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements inclu...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...sed to introduce a series of molecular diagnostics tests
to the market, including the first of those based ...HD and fetal sex determination. The first of these tests
- CFTR - is expected to launch this quarter or ear... next quarter. The RHD and fetal sex determination tests
are on target for launches thereafter.
Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
...ize these technologies and expertise to provide a menu of mutation scanning tests
for over 700 cancer-associated genes and more than 60 validated diagnostic tests
to meet the needs of pharmaceutical and biotech companies, research and cli...
BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
More information about the Company may be found at www.bioneutralgroup.com .
BioNeutral routinely tests
its formulations against those of its competitors. The results are published to let shareholders know how BioNeutral's technology compares with known...
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
...are making to develop and commercialize additional tests
to personalize the treatment of cancer. Since 200...he development and commercialization of additional tests
to personalize the treatment of cancer; the compan...ufficient levels of reimbursement for our existing tests
and any future...